Nav: Home

ACP receives four-year federal award to increase adult immunization rates

September 15, 2015

The American College of Physicians (ACP) was awarded a $1,002,884 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) to increase immunization rates in the United States. The award enables ACP to expand its seven-state evidence-based program to increase adult vaccination rates, which was funded by the CDC for 2013-15.

"Appropriate immunization of adults is a core component of preventive health care, leading to improved public health, fewer deaths, less suffering, and lower health care costs," said Wayne J. Riley, MD, MACP, president, ACP. "This award will help ACP's internal medicine physician members and their practice teams to protect their patients from serious, painful, and life-threatening diseases such as influenza, pneumococcal disease, shingles, whooping cough, measles, and others."

Fully funded by the CDC, this ACP national immunization initiative will expand its 2013-15 program piloted in partnership with state ACP chapters in Arizona, Delaware, District of Columbia, Idaho, Illinois, Maryland, New Mexico, and New York. In those states, ACP assisted 381 physicians in implementing strategies for improving adult immunization rates toward the federal government's goals for 2020, including seasonal influenza immunization rates of 80 to 90 percent of adults, depending on risk factors. The most recent data show only 42 percent of adults receives this vaccine.

Results from ACP's pilot program include increasing immunization rates for herpes zoster by 14.3 percent, high risk pneumococcal by 23.5 percent, influenza by 18.3 percent (and 25 percent for health care personnel), and Tdap by 14.7 percent.

ACP endorses the annual Advisory Committee on Immunization Practices (ACIP) Adult Immunization Schedule and advises adults to get immunized for seasonal flu and to use that opportunity to discuss with their internist other vaccinations they might need. These include Tdap to protect against tetanus; diphtheria, and pertussis (whooping cough); pneumococcal to protect against pneumonia, bacteremia, and meningitis; HPV to prevent cervical, anal, and other cancers; Hepatitis B; and herpes zoster to help prevent shingles.

"Many adults are unaware of the benefits of vaccines, the need for booster doses, and the availability of newer vaccines," Dr. Riley said. "Every year in the United States, hundreds of thousands of adults get sick, miss work, or die because of vaccine-preventable diseases or their complications. That's why ACP supports eliminating existing exemptions, except for medical reasons, from immunization laws. Allowing exemptions based on non-medical reasons poses a risk both to the unvaccinated person and to public health."
-end-
About the American College of Physicians

The American College of Physicians is the largest medical specialty organization and the second-largest physician group in the United States. ACP members include 143,000 internal medicine physicians (internists), related subspecialists, and medical students. Internal medicine physicians are specialists who apply scientific knowledge and clinical expertise to the diagnosis, treatment, and compassionate care of adults across the spectrum from health to complex illness. Follow ACP on Twitter and Facebook.

American College of Physicians

Related Influenza Articles:

Obesity promotes virulence of influenza
Obesity promotes the virulence of the influenza virus, according to a study conducted in mice published in mBio, an open-access journal of the American Society for Microbiology.
Influenza: combating bacterial superinfection with the help of the microbiota
Frenc researchers and from Brazilian (Belo Horizonte), Scottish (Glasgow) and Danish (Copenhagen) laboratories have shown for the first time in mice that perturbation of the gut microbiota caused by the influenza virus favours secondary bacterial superinfection.
Chemists unveil the structure of an influenza B protein
MIT chemists have discovered the structure of an influenza B protein called BM2, a finding that could help researchers design drugs that block the protein and help prevent the virus from spreading.
How proteins help influenza A bind and slice its way to cells
Researchers have provided new insight on how two proteins help influenza A virus particles fight their way to human cells.
Eating elderberries can help minimize influenza symptoms
Conducted by Professor Fariba Deghani, Dr. Golnoosh Torabian and Dr.
Mechanism to form influenza A virus discovered
A new study by Maria João Amorim's team, from the Gulbenkian Institute of Science, now reveals where the genomes of the influenza A virus are assembled inside infected cells.
Bat influenza viruses could infect humans
Bats don't only carry the deadly Ebola virus, but are also a reservoir for a new type of influenza virus.
New VaxArray publication on influenza neuraminidase quantification
InDevR Inc. announced publication of 'A Neuraminidase Potency Assay for Quantitative Assessment of Neuraminidase in Influenza Vaccines' in npj Vaccines.
Fighting mutant influenza
Another flu season is here, which means another chance for viruses to mutate.
Influenza vaccine delays are a problem for pediatricians
Uptake of influenza vaccine among children is low compared to other childhood vaccines, and missed opportunities for vaccination play an important role in this low uptake.
More Influenza News and Influenza Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.